The Penicillins and Streptomycins dosage market in El Salvador demonstrated a steady growth trend from 2013 to 2021, with a notable peak in 2021 where the market size stood at $27.677 million. However, a decline occurred in 2022 with a 7.32% drop, though a slight recovery was observed in 2023, reaching a value of $26.131 million. Over the last five years, the compound annual growth rate (CAGR) was 2.32%, indicating moderate growth.
Future trends to watch include:
- The impact of emerging generic medications on market dynamics.
- Potential regulatory changes affecting pharmaceutical imports.
- The role of government and private partnerships in driving market growth.
How does El Salvador rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 22 | 22 Guatemala | 39,329,000 | 2023 | +2.5% | +2.87% | View data |
| 23 | 23 Bolivia | 29,241,000 | 2023 | +3.73% | +6.7% | View data |
| 24 | 24 El Salvador | 26,131,000 | 2023 | +1.87% | +2.32% | |
| 25 | 25 Croatia | 22,712,000 | 2023 | +1.18% | +0.84% | View data |
| 26 | 26 Morocco | 20,047,000 | 2023 | -0.6% | -1.22% | View data |
